Baldwin SL - Search Results

1

Intradermal immunization improves protective efficacy of a novel TB vaccine candidate.

Baldwin SL, Bertholet S, Kahn M, Zharkikh I, Ireton GC, Vedvick TS, Reed SG, Coler RN. Baldwin SL, et al. Vaccine. 2009 May 18;27(23):3063-71. doi: 10.1016/j.vaccine.2009.03.018. Epub 2009 Mar 26. Vaccine. 2009. PMID: 19428920 Free PMC article.

2

Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis.

Bertholet S, Ireton GC, Kahn M, Guderian J, Mohamath R, Stride N, Laughlin EM, Baldwin SL, Vedvick TS, Coler RN, Reed SG. Bertholet S, et al. Among authors: baldwin sl. J Immunol. 2008 Dec 1;181(11):7948-57. doi: 10.4049/jimmunol.181.11.7948. J Immunol. 2008. PMID: 19017986 Free PMC article.

3

Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion.

Baldwin SL, Shaverdian N, Goto Y, Duthie MS, Raman VS, Evers T, Mompoint F, Vedvick TS, Bertholet S, Coler RN, Reed SG. Baldwin SL, et al. Vaccine. 2009 Oct 9;27(43):5956-63. doi: 10.1016/j.vaccine.2009.07.081. Epub 2009 Aug 11. Vaccine. 2009. PMID: 19679214

4

A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis.

Bertholet S, Ireton GC, Ordway DJ, Windish HP, Pine SO, Kahn M, Phan T, Orme IM, Vedvick TS, Baldwin SL, Coler RN, Reed SG. Bertholet S, et al. Among authors: baldwin sl. Sci Transl Med. 2010 Oct 13;2(53):53ra74. doi: 10.1126/scitranslmed.3001094. Sci Transl Med. 2010. PMID: 20944089 Free PMC article.

5

A synthetic adjuvant to enhance and expand immune responses to influenza vaccines.

Coler RN, Baldwin SL, Shaverdian N, Bertholet S, Reed SJ, Raman VS, Lu X, DeVos J, Hancock K, Katz JM, Vedvick TS, Duthie MS, Clegg CH, Van Hoeven N, Reed SG. Coler RN, et al. Among authors: baldwin sl. PLoS One. 2010 Oct 27;5(10):e13677. doi: 10.1371/journal.pone.0013677. PLoS One. 2010. PMID: 21060869 Free PMC article.

6

Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions.

Baldwin SL, Fox CB, Pallansch MA, Coler RN, Reed SG, Friede M. Baldwin SL, et al. Vaccine. 2011 Jan 17;29(4):644-9. doi: 10.1016/j.vaccine.2010.11.043. Epub 2010 Dec 4. Vaccine. 2011. PMID: 21134451

7

Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant.

Coler RN, Bertholet S, Moutaftsi M, Guderian JA, Windish HP, Baldwin SL, Laughlin EM, Duthie MS, Fox CB, Carter D, Friede M, Vedvick TS, Reed SG. Coler RN, et al. Among authors: baldwin sl. PLoS One. 2011 Jan 26;6(1):e16333. doi: 10.1371/journal.pone.0016333. PLoS One. 2011. PMID: 21298114 Free PMC article.

8

Transcriptional profiling of TLR-4/7/8-stimulated guinea pig splenocytes and whole blood by bDNA assay.

Ching LK, Mompoint F, Guderian JA, Picone A, Orme IM, Coler RN, Reed SG, Baldwin SL. Ching LK, et al. Among authors: baldwin sl. J Immunol Methods. 2011 Oct 28;373(1-2):54-62. doi: 10.1016/j.jim.2011.07.021. Epub 2011 Aug 3. J Immunol Methods. 2011. PMID: 21839740 Free PMC article.

9

Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.

Fox CB, Baldwin SL, Duthie MS, Reed SG, Vedvick TS. Fox CB, et al. Among authors: baldwin sl. Vaccine. 2011 Nov 28;29(51):9563-72. doi: 10.1016/j.vaccine.2011.08.089. Epub 2011 Sep 9. Vaccine. 2011. PMID: 21906648 Free PMC article.

10

The importance of adjuvant formulation in the development of a tuberculosis vaccine.

Baldwin SL, Bertholet S, Reese VA, Ching LK, Reed SG, Coler RN. Baldwin SL, et al. J Immunol. 2012 Mar 1;188(5):2189-97. doi: 10.4049/jimmunol.1102696. Epub 2012 Jan 30. J Immunol. 2012. PMID: 22291184 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page